Latest News Posted on April 23, 2021 A new study published on the bioRxiv* preprint server focuses on the in-silico predictions to repurpose existing drug compounds, that may have the ability to reverse the SARS-CoV-2 gene expression induced in host cells. Leave a Reply Cancel replyYou must be logged in to post a comment.